European Health Economics
text size:

2009-12-03 : Neurology

Kobelt G, Kasteng F. The burden of Multiple Sclerosis and access to innovative treatments in Europe. A report. www.comparatorreports.se.

2009-10-12 : Rheumatology

Kobelt G, Kasteng F. The burden of Rheumatoid Arthritis and access to innovative treatments in Europe. A Report. www.comparatorreports.se

2009-09-21 : Rheumatology

Kobelt G, Lindgren P, Geborek P. Costs and outcomes for patients with rheumatoid arthritis treated with biological drugs in Sweden: a model based on registry data. Scand J Rheumatol 2009;38:409-419

2009-06-01 : Neurology

Kobelt.G, Texier-Richard B, Lindgren P. The longterm cost of multiple sclerosis in France and potential changes with disease modifying agents. Multiple Sclerosis 2009;15:741-751

2009-05-01 : Ophthalmology

The cost of treating glaucoma with prostaglandins in France: a 4-year follow-up in routine clinical practice.

2009-03-01 : Rheumatology

Lindgren P, Kobelt G. Modelling the cost of rituximab in Sweden. Int J Technol Assess Health Care 2009;2:181-189

TopGo to top

© 2003 European Health Economics. All rights reserved. Created by MedSciNet AB.